Trust In AI Agents Has To Be Earned Continuously, Not Just Once

As AI agents take on a growing role in clinical trial operations, trust depends on more than initial validation. Adaptive models, evolving knowledge sources, and changing workflows can all influence performance over time, creating new requirements for governance in regulated environments.

Continuous monitoring, version control, audit-ready traceability, and documented change management help ensure AI-driven processes remain reliable, explainable, and compliant throughout a study lifecycle. Key considerations include detecting performance drift, responding to model and workflow updates, maintaining complete audit trails, and generating evidence that supports regulatory readiness.

Learn how a continuous governance approach can help clinical teams validate AI performance on an ongoing basis, strengthen oversight, and deploy agentic technologies with greater confidence in high-stakes research settings.